🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

Thai government foe ordered to erase vaccine supply criticism

Published 2021-01-31, 07:39 a/m
© Reuters. FILE PHOTO: Thai banned opposition politician holds news conference on royal company's role in vaccine strategy
PGR
-
META
-

By Panu Wongcha-um

BANGKOK (Reuters) - A Thai court has ordered a leading government foe to remove allegations on social media that the state's coronavirus vaccine policy is opaque and unfairly favours a company owned by the king, the government said on Sunday.

However, opposition politician Thanathorn Juangroongruangkit's Progressive (NYSE:PGR) Movement denied the videos were illegal and urged YouTube and Facebook (NASDAQ:FB) to preserve freedom of expression.

The clips could still be viewed late on Sunday.

Thailand's Digital Ministry said the Criminal Court ruled that Thanathorn's posts on social media and his movement's website could breach national security.

The videos accuse Prime Minister Prayuth Chan-ocha's government of lack of transparency in allowing Siam Bioscience, which is owned by King Maha Vajiralongkorn, to supply most doses despite a lack of vaccine experience.

Critics say former junta leader Prayuth rigged a vote in a 2019 election to retain power - a charge he denies - and have broken a national taboo by increasingly criticising the monarchy.

SUBSIDY

Siam Bioscience received a 600 million baht ($20 million) subsidy to develop capacity to manufacture AstraZeneca vaccines domestically and across Southeast Asia.

The court did not comment when contacted by Reuters.

Thanathorn's movement said it had not received the ruling. "We continue to stress that the content is not false or a threat to national security," tweeted Pannika Wanich, a prominent Progressive Movement member.

"We hope YouTube and Facebook will stand by the rights and freedom of expression."

Thanathorn was banned from politics for 10 years after a court dissolved his previous Future Forward Party last year over loans deemed illegal. He denied the charges.

Now the government has lodged a case against him over the video, accusing him of insulting royalty, a charge punishable by up to 15 years' prison.

The government says Siam Bioscience manufacturing is on track to deliver a first batch of 61 million doses to the public by June.

There was no immediate comment from Thanathorn or Siam Bioscience on the court ruling. The palace traditionally does not comment on political disputes.

Relatively unscathed by COVID-19, Thailand on Sunday reported 829 new coronavirus cases, bringing the total to 18,782 cases and 77 fatalities since the outbreak started last January.

© Reuters. FILE PHOTO: Thai banned opposition politician holds news conference on royal company's role in vaccine strategy

(This story corrects election date to 2019 from last year in sixth paragraph)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.